View Today's Schedule
Nilanjana Bhowmik, Co-Founder of Converge brings rigorous focus on B2B tech as a co-Founder of Converge, an early-stage venture capital firm, drawing on her 23 years as a venture capitalist, investment banker, and operating executive. Prior to founding Converge, Nilanjana was a General Partner at Longworth Venture Partners where she led the firm’s investments in enterprise tech. As an investment banker at Broadview (now Jefferies), Nilanjana executed numerous M&A transactions of leading enterprise tech companies and led the bank’s research publications of market maps on middleware, application, and security software.
Marcus O. P. DeFlorimonte, Owner and Managing Partner of Hampstead LLC is a real estate investor and developer in Boston, MA. Prior to building his real estate business, Marcus had a 20 plus year career in general management in the government and non-profit sectors. He managed programs and services for youth, adults, and senior citizens. He led collaborative efforts involving the non-profit, public, and private sectors to develop and implement comprehensive social, educational, and health services for diverse communities.
Dr. Cigall Kadoch, Associate Professor of Pediatric Oncology at the Dana-Farber Cancer Institute and Epigenomics Program Co-Director at the Broad Institute of MIT and Harvard is an academic leader and entrepreneur in biomedical sciences. She is also the Scientific Founder of Foghorn Therapeutics (NASDAQ: FHTX). As one of the youngest scientists to ever be appointed to the Harvard Medical School faculty, Dr. Kadoch established her independent laboratory in 2014 at the age of 28, immediately following completion of her PhD studies at Stanford University. She is a leading expert in chromatin and gene regulation and is internationally recognized for her groundbreaking studies in these areas.
Rebecca Kantar, Head of Education and Entrepreneur in Residence at Roblox Corporation is an entrepreneur who founded and sold two technology companies. Roblox Corporation (NYSE: RBLX) acquired Ms. Kantar’s company, Imbellus, a simulation-based assessment technology company. At Imbellus, Ms. Kantar raised over $23M to develop and operationalize simulation-assessments that could measure deep thinking skills. At Roblox, a technology platform bringing the world together through play, Ms. Kantar leads internal assessment work and Roblox’s global education initiatives. Ms. Kantar previously founded and sold an expert-network to Gerson Lehrman Group.
Dr. Feng Zhang, molecular biologist, is a core member of the Broad Institute, an Investigator at the McGovern Institute for Brain Research, the James and Patricia Poitras Professor of Neuroscience at MIT, and a Howard Hughes Medical Investigator. Dr. Zhang is a molecular biologist focused on improving human health. He played an integral role in the development of two revolutionary technologies, optogenetics and CRISPR- Cas systems, including pioneering the use of Cas9 for genome editing and discovering CRISPR-Cas12 and Cas13 systems and developing them for therapeutic and diagnostics applications.